skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Pituitary Ca/sup 2 +/ channels: blockade by conventional and novel Ca/sup 2 +/ antagonists

Journal Article · · Am. J. Physiol.; (United States)
OSTI ID:6143081

The authors have identified several new agents that block Ca/sup 2 +/ channels in the rat pituitary GH/sub 4/C/sub 1/ cell line. These drugs, which include the diphenylbutylpiperidine antipsychotic pimozide, the calmodulin antagonist calmidazolium, and the steroidal Na/sup +/ channel toxin veratridine, were compared with several conventional Ca/sup 2 +/ antagonists in /sup 45/Ca/sup 2 +/ uptake, prolactin secretion, and whole cell patch voltage-clamp experiments. Pimozide, the most potent of these novel Ca/sup 2 +/ antagonists, inhibited depolarization-dependent /sup 45/Ca/sup 2 +/ uptake and prolactin secretion half maximally at a concentration of 100 nM, whereas calmidazolium and veratridine produced 50% inhibition at concentrations of 500 nM and 1 ..mu..M. In comparison, the three organic Ca/sup 2 +/ antagonists nitrendipine, verapamil, and diltiazem blocked /sup 45/Ca/sup 2 +/ uptake half maximally at concentrations of 2.5 nM, 1 ..mu..M, and 2.5 ..mu..M, respectively. All of the antagonists inhibited Ca/sup 2 +/ uptake and prolactin secretion stimulated by the dihydropyridine Ca/sup 2 +/ agonist BAY-K 8644 less potently than KCl-stimulated responses. In patch-clamp experiments, pimozide, veratridine, and nitrendipine blocked Ca/sup 2 +/ current through the slowly inactivating Ca/sup 2 +/ channels of GH/sub 4/C/sub 1/ cells. These results demonstrate that Ca/sup 2 +/ channels in an endocrine cell line can be blocked by a variety of molecules including sodium channel toxins and calmodulin antagonists. The data extend the pharmacological similarity between Ca/sup 2 +/ channels in pituitary and other excitable cells and suggest a structural similarity among several cellular proteins.

Research Organization:
Univ. of Rochester School of Medicine and Dentistry, NY (USA)
OSTI ID:
6143081
Journal Information:
Am. J. Physiol.; (United States), Vol. 253:1
Country of Publication:
United States
Language:
English